Nick Galakatos
InvestorGlobal Head of Blackstone Life Sciences at Blackstone Life Sciences
Find your path to Nick
31 people in our graph share verified history with Nick — schools, employers, funds. One of them is your warm intro.
Jim BreyerunlockedNick: together at Blackstone Life Sciences
×11Nick: together at Blackstone Life Sciences
About
Global Head of Blackstone Life Sciences, known for a differentiated approach to life sciences investing and risk mitigation.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Investments
Board seats
Anthos TherapeuticsBioMed RealtyNeurvatiTransForm Pharmaceuticals
Per the firm's website.
Colleagues at Blackstone Life Sciences
Aitian Li
Investment Associate at Calculus Capital Ltd.
Alicia Novak
Executive Officer at Blackstone Life Sciences
Amaan Irfan Furniturewala
Scout at Immersion Partners
Ari Brettman
Senior Managing Director at Blackstone Life Sciences
Barry Gertz
Managing Director at Blackstone Life Sciences
Chris Placca
Executive Officer at Blackstone Life Sciences
Christopher Striano
Executive Officer at Blackstone Life Sciences
Colm Foley
Managing Director at Blackstone Life Sciences
Frequently asked questions
- Who is Nick Galakatos?
- Global Head of Blackstone Life Sciences, known for a differentiated approach to life sciences investing and risk mitigation.
- Where does Nick Galakatos work?
- Nick Galakatos is Global Head of Blackstone Life Sciences at Blackstone Life Sciences.
- What does Nick Galakatos invest in?
- Nick Galakatos invests in Biotech, Healthtech, Medical Devices.
- What boards does Nick Galakatos sit on?
- Nick Galakatos holds tracked board seats at Anthos Therapeutics, BioMed Realty, Neurvati, TransForm Pharmaceuticals.